GL1X · GenesisL1 explorer

Research workbench

Crystal structure of protease inhibitor, mit-2-AD86 in complex with wild type HIV-1 protease

Analyse Crystal structure of protease inhibitor, mit-2-AD86 in complex with wild type… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2QI7
Type
protein
Length
198 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Protease
UniProt
O38732
Ligands
MZ9, PO4
Pockets
1 · best druggability 0.70

Structure

x-ray diffraction · 1 distinct chain · 4% helix, 54% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BProteaseprotein994% helix, 54% strandO38732

Ligands and binding sites

  • MZ9 · N-[(1S,2R)-1-benzyl-2-hydroxy-3-{[(4-methoxyphenyl)sulfonyl][(2s)-2-methylbutyl]amino}propyl]-4-oxohexanamide · ligand · chains A, B
  • PO4 · Phosphate ion · ion · 2 copies · chains A, B
  • ACT · Acetate ion · additive · 3 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13660.700.8238MZ9

Interfaces

1 interface between chains.

  • A–B · 1852 Ų buried · 42 hydrogen bonds · protein-protein

Compared structures

  • 2QI7 · Crystal structure of protease inhibitor, MIT-2-AD86 in complex with wild type HIV-1… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.